gastroesophageal variceal bleeding
Conditions
Interventions
PTVE group:treated by a modified percutaneous transhepatic variceal embolization with 2-Octyl Cyanoacrylate
TIPS group:treated by transjugular intrahepatic portosystemic stent
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. cirrhotic patients with acute or recent (within 3 months) esophageal variceal hemorrhage; and 2. the degree of gastroesophageal varices was F2 or F3 in these patients, as revealed by gastroendoscopy.
Exclusion criteria
Exclusion criteria: Patients were exclude if they presented with one or more of the following: 1. association with hepatocellular carcinoma or other malignancy; 2. severe jaundice with serum bilirubin more than 100 mg L-1; 3. encephalopathy greater than stage II; 4. history of endoscopic treatment for esophageal varices for example EIS or EVL; 5. presence of hepatorenal failure with serum creatinine greater than 2 mg dL -1; 6. complete obstruction of the portal vein due to thrombos or other reasons; 7. severe infection ,especially biliary tract infection; 8. Budd-Chiari syndrome; 9. polycystic liver; 10. heart failure; 11. inability or refusal to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| eradication of varices;varices recurrent rate;encephalopathy;Survival;rebleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| patency rate in TIPS group;liver child-pugh classifaction;distribution of 2-OCA scanned by CT.;complication; | — |
Countries
China
Contacts
Public ContactC. Q. Zhang
Outcome results
None listed